Second engine igniting off the first: an unplanned-for adjacent revenue stream has started paying, and management is now
The model's full reasoning — Q3 2022 call → NOWe need to determine if the transcript describes a second, distinct way of making money that emerged from existing operations, is already generating real paying business, and is being deliberately grown. Let's analyze the transcript. The company is SI-BONE, which makes products for SI joint fusion, spinal pelvic fixation, and pelvic trauma. Their core business is minimally invasive SI joint fusion using iFuse-3D. They have expanded into adult deformity with iFuse-Bedrock Granite and trauma with iFuse-TORQ. The question asks: does management describe a second, distinct way of making money that emerged from existing operations, assets, customers, or capabilities? And is it already generating real paying business and being deliberately grown? We need to see if they talk about a separate revenue stream that is not just more sales of the same product to the same customers. For example, they might be monetizing something like a technology, a data, a byproduct, or a new customer segment. Looking at the transcript, they talk about their products: iFuse-3D, iFuse-TORQ, iFuse-Bedrock Granite. These are all part of their portfolio. They are selling these products to surgeons for different indications. Is that a second avenue? It's more like product line extensions. They are selling to the same surgeons (spine surgeons) for different procedures. That might be considered cross-selling or upselling, not a distinct second way of making money. They also talk about their training programs, but that's not a revenue stream. They mention their patient awareness initiatives, but that's marketing. They mention their international business, but that's geographic expansion, not a distinct avenue. They mention their sales force and distribution, but that's not a second revenue stream. They mention their research, but that's not revenue. The key is: is there a second way of making money that grew out of the first? For example, if they had a technology that they now license to others, or if they use their data to sell insights, or if they have a service business on top of their product sales. In the transcript, they talk about their products and their expansion into trauma and adult deformity. These are new products for new indications, but they are still selling implants to surgeons. That's the same business model: selling medical devices.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| M | Macy's, Inc. | Q4 2022 | 2023-03-02 | D |
| CMLS | Cumulus Media Inc. | Q3 2022 | 2022-10-28 | D |
| GDRX | GoodRx Holdings, Inc. | Q2 2022 | 2022-08-08 | F |
| SOPH | SOPHiA GENETICS SA | Q4 2021 | 2022-03-15 | C |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
LRN · Q1 2019 → YESThe question is: Does management describe a SECOND, DISTINCT WAY OF MAKING MONEY that has recently emerged FROM the company's existing operations, assets, customers, or capabilities - an additional re...YES The transcript shows career readiness as a distinct second revenue avenue that emerged directly from the existing MPS business: students already enrolled in Managed Public Schools are being moved into career readiness programs (over 5,000 students), and the initiative is built on the same platform, curriculum, and student base. Management explicitly describes it as a “career readiness line of business” and “robust career readiness business” that is already generating paying enrollments today while they are deliberately investing resources—dedicated executives, reallocation of funds, and plans to drive a major portion of next year’s enrollment growth.
M · Q4 2022 → YESThe question is: Does management describe a SECOND, DISTINCT WAY OF MAKING MONEY that has recently emerged FROM the company's existing operations, assets, customers, or capabilities - an additional re...YES The transcript shows that Macy’s Marketplace is explicitly described as a distinct new revenue avenue that emerged directly from their existing e-commerce operations and customer base (macys.com, cross-shoppers, and omnichannel platform). Jeff Gennette states it “captures incremental sales opportunity,” “drives a larger average order value,” “allows us to quickly move into new and adjacent categories without inventory risk,” and “attracts a new younger customer,” while management is actively scaling it by adding 2,000 brands in 2023 and launching Bloomingdale’s marketplace in the back half.
GDRX · Q2 2022 → YESThe question is: Does management describe a SECOND, DISTINCT WAY OF MAKING MONEY that has recently emerged FROM the company's existing operations, assets, customers, or capabilities - an additional re...YES The transcript shows that Pharma Manufacturer Solutions is the second distinct revenue avenue that emerged from GoodRx’s existing operations. Trevor explicitly states: “Our distinct ability to reach both consumers and providers continues to be recognized by manufacturers as evidenced by the strong growth.” This capability originated from the core prescription-transactions platform and user base 3 years earlier (when other offerings were only ~5% of revenue). In Q2 2022 it generated $26.6 million (102% YoY growth) and is already producing real paying business.